Studysummary This narrative review provides an overview of the persistent dermatological side effects experienced by cancer survivors due to treatments, highlighting their impact on quality of life and the need for structured dermatological care during survivorship.
Read the full study on link.springer.com →
Research cited in this study 42
- Expert Consensus for Prevention, Diagnosis and Management of Persistent Chemotherapy-Induced Alopecia PubMed · 2025
- Platelet-Rich Plasma Treatment for Endocrine-Induced Alopecia and Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors: A Randomized, Controlled, Pilot Study Dermatologic Surgery · 2025
- Assessment of Long-Term Alopecia After Adjuvant Taxane Therapy for Early Breast Cancer: A Cross-Sectional Survey Supportive Care in Cancer · 2025
- Safety First: A Comprehensive Review of Nutritional Supplements for Hair Loss in Breast Cancer Patients Nutrients · 2025
- Erosive Pustular Dermatosis of the Scalp Due to EGFR Inhibitors: A Multicentric Study by EADV Task Force of Dermatology for Cancer Patients Journal of the European Academy of Dermatology and Venereology · 2025
- Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment, and Prevention Current Oncology · 2024
- Vorasidenib-Induced Trichomegaly and Hypertrichosis: A New Side Effect in a Patient with Diffuse Astrocytoma Dermatology and Therapy · 2024
- Oral Minoxidil for Late Alopecia in Cancer Survivors Breast Cancer Research and Treatment · 2024
- Folliculitis Decalvans-Like Alopecia During EGFR Inhibitors Treatment for Lung Cancer: A Case Series of 6 Patients Dermatology practical & conceptual · 2023
- Persistent Chemotherapy-Induced Alopecia Treated With Low Dose Oral Minoxidil: A Multicenter Retrospective Case Series of 15 Patients Dermatology practical & conceptual · 2023
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force Dermatology for Cancer Patients International Study Cancers · 2023
- Skin Pigmentation Types, Causes and Treatment: A Review Molecules · 2023
- EGFR Inhibitor-Induced Folliculitis Decalvans: A Case Series and Management Guidelines Anti-Cancer Drugs · 2023
- Association of Spironolactone Use With Risk of Cancer: A Systematic Review and Meta-Analysis JAMA Dermatology · 2022
- Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors JAMA Dermatology · 2021
- Erosive Pustular Dermatosis of the Scalp Induced by Gefitinib: Case and Review of the Literature Dermatology Online Journal · 2021
- Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Cancer Patients JAMA dermatology · 2020
- Topical and Oral Minoxidil for Hair Disorders in Pediatric Patients: What Do We Know So Far? Dermatologic Therapy · 2020
- Prevention and Treatment of Chemotherapy-Induced Alopecia Dermatology practical & conceptual · 2020
- Scalp Cooling to Prevent Chemotherapy-Induced Alopecia Anais brasileiros de dermatologia/Anais Brasileiros de Dermatologia · 2020
- Spironolactone Use Does Not Increase the Risk of Female Breast Cancer Recurrence: A Retrospective Analysis Journal of The American Academy of Dermatology · 2020
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails American Journal of Clinical Dermatology · 2018
- Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study The oncologist · 2018
- Monitoring Chemotherapy-Induced Alopecia With Trichoscopy Journal of Cosmetic Dermatology · 2018
- Persistent Major Alopecia Following Adjuvant Docetaxel for Breast Cancer: Incidence, Characteristics, and Prevention with Scalp Cooling Breast Cancer Research and Treatment · 2018
- Hair Disorders in Patients with Cancer Journal of The American Academy of Dermatology · 2018
- Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer JAMA Dermatology · 2018
- Erosive Pustular Dermatosis of the Scalp: Clinical, Trichoscopic, and Histopathologic Features of 20 Cases Journal of The American Academy of Dermatology · 2017
- The Incidence and Management of Cutaneous Adverse Events of the Epidermal Growth Factor Receptor Inhibitors Postępy Dermatologii i Alergologii · 2017
- Dermatological Adverse Events with Taxane Chemotherapy European Journal of Dermatology · 2016
- Hair and Nail Adverse Events During Treatment with Targeted Therapies for Metastatic Melanoma European journal of dermatology/EJD. European journal of dermatology · 2016
- Topical Retinoids: Therapeutic Mechanisms in the Treatment of Photodamaged Skin American journal of clinical dermatology · 2016
- Cutaneous Adverse Effects of Targeted Therapies Journal of the American Academy of Dermatology · 2015
- Long-Term Safety and Efficacy of Bimatoprost Solution 0.03% Application to the Eyelid Margin for the Treatment of Idiopathic and Chemotherapy-Induced Eyelash Hypotrichosis: A Randomized Controlled Trial British journal of dermatology/British journal of dermatology, Supplement · 2014
- Aromatase Inhibitor Therapy and Hair Loss Among Breast Cancer Survivors Breast Cancer Research and Treatment · 2013
- Pathobiology of Chemotherapy-Induced Hair Loss The Lancet Oncology · 2013
- Permanent Alopecia After Systemic Chemotherapy: A Clinicopathological Study of 10 Cases The American Journal of Dermatopathology · 2011
- Best Practice Options for Hair Removal in Patients with Unwanted Facial Hair Using Combination Therapy with Laser: Guidelines by an Expert Working Group Dermatology · 2010
- Classification and Management of Skin, Hair, Nail, and Mucosal Side Effects of Epidermal Growth Factor Receptor Inhibitors European journal of cancer · 2007
- The PRIDE Syndrome: Dermatological Side Effects of EGFR Inhibitors British Journal of Dermatology · 2006
- Drug-Induced Hair Disorders Current Drug Safety · 2006
- A Randomized Trial of Minoxidil in Chemotherapy-Induced Alopecia Journal of The American Academy of Dermatology · 1996
